Problem Jantung pada Penyakit Kawasaki
Abstract
Penyakit Kawasaki merupakan penyakit akut, vaskulitis yang sembuh sendiri (self-limited).Penyakit ini menyerang bayi dan anak-anak, penyebabnya tidak diketahui. Tomisaku Kawasaki menemukan kasus pertama tahun 1961 pada anak usia 4 tahun yang menderita demam dengan bercak kemerahan. Pada tahun 1967, Kawasaki melihat 50 pasien dengan gejala yang sama, yaitu demam akut disertai eksantema dan menegakkan diagnosisnya sebagai mucocutaneus lymph node syndrome.Penyakit tersebut mulai dikenal luas di luar Jepang sejak tahun 1974 setelah Kawasaki melaporkannya dalam suatu jurnal di Inggris.
Downloads
Download data is not yet available.
References
Kawasaki T. Acute febrile mucocutaneus lymphnode syndrome with accompanying spesific peeling of the fingers and the toes. Japanes J Allergy 1967;16:178-22.
Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneus lymphnode syndrome (MNLS) prevailing in Japan. Pediatrics 1974;54:271-76.
Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364:533-44.
Kato H, Sugimura T, Akagi T. Long-term consequences of Kawasaki disease. A 10 to 21 year follow-up study of 594 patients. Circulation 1996; 94:1379-85.
Dajani AS, Taubert KA, Gerber MA. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004;114:1708-33.
Freeman AF, Shulman ST. Kawasaki disease : Sumamary of the American Heart Association Guidelines. Am Fam Physician 2006;74:1141-8.
Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991;119:279-82.
Han RK, Sinclair B, Newman A, Silverman ED, Taylor GW, Walsh P, et al. Recognition and management of Kawasaki disease. CMAJ 2000;162(6):807-12.
Melish ME. Kawasaki syndrome. Pediatric in Review 1996;17:153-62.
Burns JC, Wiggin JW, Toews WH. The Clinical spectrum of Kawasaki syndrome in infants less than six months of age. J Pediatr 1986;109: 759-63.
Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants than one year of age. J Pediatr 1995;126:524-29.
Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr 2000;137:250-52.
Newburger JW, Taubert KA, Shulman ST. Summary and abstracts of the seventh international kawasaki disease symposium. Pediatr Res 2003;53:153-87.
Hirata S, Nakamura Y, Yanagawa H. Insidence rate of recurrent Kawasaki disease and related risk factor: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 2001;90:40-44.
Yanagawa H, Nakamura Y, Yashiro M. Incidens survey of kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:E33.
Chang RK. The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997. Pediatrics 2003;111:1124-25.
Burnst JC, Glode MP, Clarke SH, Wiggins J, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of artery aneurysms. J Pediatr 1984;105:206-11.
Yamashiro Y, Nagata S, Oguchi S, Shimizu T. Selective increase of Vß2 T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res 1996;39:264-66.
Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001;184:940-43.
Suzuki A, Miyagawa-Tomita S, Komatsu K. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease:immunohistochemical study. Circulation 2000; 101:2935-41.
Nagata S, Yamashiro Y, Maeda M, Ohtsuka Y, Yabuta K. Immunohistochemical studies on small intestinal mucosa in Kawasaki disease. Pediatr Res 1993;33:557-63.
Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr 1992;120:926-28.
Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation 1991;84:625-31.
de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be mis-classified as normal in Kawasaki disease. J Pediatr 2002;44:1-4.
Kurotobi S, Nagai T, Kawakami N, SanoT. Coronary diameter in normal infants, children, and patients with Kawasaki disease. Pediatr Int 2002;44:1-4.
McMorrow Tuohy Am, Tani LY, Cetta F. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease?. Am J Cardiol. 2001;88:328-30.
Hiraisi S, Yashiro K, Oguchi K, Ishii K, Nakazawa K. Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome. Relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol 1981;47:323-30.
Moran AM, Newburger JW, Sanders SP. Abnormal myocardial mechanics in Kawasaki disease:rapid response to gamma-globulin. Am Heart J 2000;139:217-23.
Kato H, Sugimara T, Akagi T. Long-term consequences of kawasaki disease. A 10- to 21 year follow-up study of 594 patients. Circulation 1996;94:1379-85.
Gidding SS, Shulman ST, Ilbawi M, Crussi F, Duffy CE. Mucocutaneous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol 1986;7:894-97.
Ravekes WJ, Colan SD, Gauvreau K. Aortic root dilatation in Kawasaki disease. Am J Cardiol 2001;87:919-22.
Catella-Lawson F, Reilly MP, Kapoor SC. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001;345:1809-17.
Furusho K, Kamiya T, Nakano H. High-dose intravenous gammaglobulin for kawasaki disease. Lancet 1984;2:1055-58.
Newburger JW, Takahashi M, Burns JC. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Eng j Med 1986;315:341-47.
Marasini M, Pongiglione G, Gazzalo D, Campelli A, Ribaldone D, Caponnetto S. Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities. Am J Cardiol 1991;68:796-97.
Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr. 1999;135:465-69.
Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease:report of a randomized trial. J Pediatr. 2003;142:611-16.
Gerschutz GP, Bhatt DL. The clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study:to what extent should the results be generalizable? Am Heart J. 2003;145:595-601.
Lange RA, Hillis LD. Reperfusion therapy in acute myocardial infarction. N Eng J Med. 2002;346:954-55.
Tsuda E, Kitamura S. Cooperative Study Group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 2004;110:II61-II66.
Ishii M, Ueno T, Akagi T. Sequnetial follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 2002;105:3004-3010.
Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneus lymphnode syndrome (MNLS) prevailing in Japan. Pediatrics 1974;54:271-76.
Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364:533-44.
Kato H, Sugimura T, Akagi T. Long-term consequences of Kawasaki disease. A 10 to 21 year follow-up study of 594 patients. Circulation 1996; 94:1379-85.
Dajani AS, Taubert KA, Gerber MA. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004;114:1708-33.
Freeman AF, Shulman ST. Kawasaki disease : Sumamary of the American Heart Association Guidelines. Am Fam Physician 2006;74:1141-8.
Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991;119:279-82.
Han RK, Sinclair B, Newman A, Silverman ED, Taylor GW, Walsh P, et al. Recognition and management of Kawasaki disease. CMAJ 2000;162(6):807-12.
Melish ME. Kawasaki syndrome. Pediatric in Review 1996;17:153-62.
Burns JC, Wiggin JW, Toews WH. The Clinical spectrum of Kawasaki syndrome in infants less than six months of age. J Pediatr 1986;109: 759-63.
Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants than one year of age. J Pediatr 1995;126:524-29.
Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr 2000;137:250-52.
Newburger JW, Taubert KA, Shulman ST. Summary and abstracts of the seventh international kawasaki disease symposium. Pediatr Res 2003;53:153-87.
Hirata S, Nakamura Y, Yanagawa H. Insidence rate of recurrent Kawasaki disease and related risk factor: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 2001;90:40-44.
Yanagawa H, Nakamura Y, Yashiro M. Incidens survey of kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:E33.
Chang RK. The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997. Pediatrics 2003;111:1124-25.
Burnst JC, Glode MP, Clarke SH, Wiggins J, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of artery aneurysms. J Pediatr 1984;105:206-11.
Yamashiro Y, Nagata S, Oguchi S, Shimizu T. Selective increase of Vß2 T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res 1996;39:264-66.
Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001;184:940-43.
Suzuki A, Miyagawa-Tomita S, Komatsu K. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease:immunohistochemical study. Circulation 2000; 101:2935-41.
Nagata S, Yamashiro Y, Maeda M, Ohtsuka Y, Yabuta K. Immunohistochemical studies on small intestinal mucosa in Kawasaki disease. Pediatr Res 1993;33:557-63.
Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr 1992;120:926-28.
Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation 1991;84:625-31.
de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be mis-classified as normal in Kawasaki disease. J Pediatr 2002;44:1-4.
Kurotobi S, Nagai T, Kawakami N, SanoT. Coronary diameter in normal infants, children, and patients with Kawasaki disease. Pediatr Int 2002;44:1-4.
McMorrow Tuohy Am, Tani LY, Cetta F. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease?. Am J Cardiol. 2001;88:328-30.
Hiraisi S, Yashiro K, Oguchi K, Ishii K, Nakazawa K. Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome. Relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol 1981;47:323-30.
Moran AM, Newburger JW, Sanders SP. Abnormal myocardial mechanics in Kawasaki disease:rapid response to gamma-globulin. Am Heart J 2000;139:217-23.
Kato H, Sugimara T, Akagi T. Long-term consequences of kawasaki disease. A 10- to 21 year follow-up study of 594 patients. Circulation 1996;94:1379-85.
Gidding SS, Shulman ST, Ilbawi M, Crussi F, Duffy CE. Mucocutaneous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol 1986;7:894-97.
Ravekes WJ, Colan SD, Gauvreau K. Aortic root dilatation in Kawasaki disease. Am J Cardiol 2001;87:919-22.
Catella-Lawson F, Reilly MP, Kapoor SC. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001;345:1809-17.
Furusho K, Kamiya T, Nakano H. High-dose intravenous gammaglobulin for kawasaki disease. Lancet 1984;2:1055-58.
Newburger JW, Takahashi M, Burns JC. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Eng j Med 1986;315:341-47.
Marasini M, Pongiglione G, Gazzalo D, Campelli A, Ribaldone D, Caponnetto S. Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities. Am J Cardiol 1991;68:796-97.
Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr. 1999;135:465-69.
Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease:report of a randomized trial. J Pediatr. 2003;142:611-16.
Gerschutz GP, Bhatt DL. The clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study:to what extent should the results be generalizable? Am Heart J. 2003;145:595-601.
Lange RA, Hillis LD. Reperfusion therapy in acute myocardial infarction. N Eng J Med. 2002;346:954-55.
Tsuda E, Kitamura S. Cooperative Study Group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 2004;110:II61-II66.
Ishii M, Ueno T, Akagi T. Sequnetial follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 2002;105:3004-3010.
Views & Downloads
Abstract views: 3266
PDF (Bahasa Indonesia) downloads: 3903
PDF (Bahasa Indonesia) downloads: 3903
How to Cite
Budiyanto, N. (1). Problem Jantung pada Penyakit Kawasaki. Indonesian Journal of Cardiology, 28(4), 285-296. https://doi.org/10.30701/ijc.v28i4.232
Issue
Section
Review Article
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
